Canine Influenza Treatment Market Analysis with Focus on Opportunities, Development Strategies to 2028

Canine influenza is also called dog flu. It is an infectious respiratory disease that spreads in an airborne and aerosolized manner in dogs, caused by Type A influenza viruses. So far, no human infections with canine influenza have been reported. Canine influenza is done in two segments are H3N8 virus and the H3N2 (seasonal influenza A) virus. Canine influenza of H3N8 viruses done in horses spread to dogs and spread among dogs. The canine influenza H3N8 virus was first reported in 2004 in the U.S. Canine influenza of H3N2 viruses observed in birds spread to dogs and spread among dogs.

Download PDF Sample Copy at:
https://www.theinsightpartners.com/sample/TIPRE00022898/?utm_source=OpenPR&utm_medium=10376

MARKET SEGMENTATION

- Based on type, the global canine influenza treatment market is segmented into antibiotics, nonsteroidal anti-inflammatory drugs (nsaids), antiviral drugs, others.
- On the basis of distribution channel, the market is segmented into veterinary clinics, veterinary pharmacies, online pharmacies, others.

MARKET DYNAMICS
Drivers:

- Rise in the incidences of Canine Influenza.
Lower cost of procedure as compared to conventional methods.
- Growing pet adoptions globally.
Rise in FDA and research institutes.

Restraints:

- The limited numbers of vaccine are the major restraining factor for this market.

IMPACT OF COVID-19 ON CANINE INFLUENZA TREATMENT MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Have a Call with Analyst:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00022898/?utm_source=OpenPR&utm_medium=10376

Key Players:

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the canine influenza treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

Merck Animal Health
Pfizer
Sanofi
Zoetis
Novartis
Bristol-Myers Squibb
Eli Lilly and Company
Boehringer Ingelheim International
Roche
GlaxoSmithKline

Buy Report at:
https://www.theinsightpartners.com/buy/TIPRE00022898/?utm_source=OpenPR&utm_medium=10376

Contact us:

If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-987

About The Insight Partners:

The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Manufacturing and Construction, Technology, Chemicals and Materials.
We offer our clients multiple ways to customize research as per their specific needs and budget.

This release was published on openPR.